2-166280508-A-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001365536.1(SCN9A):​c.2192T>A​(p.Ile731Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,589,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I731T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 0 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

5
7
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:9B:6

Conservation

PhyloP100: 7.39

Publications

9 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.20788541).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.2192T>A p.Ile731Lys missense_variant Exon 14 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.2192T>A p.Ile731Lys missense_variant Exon 14 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.2192T>A p.Ile731Lys missense_variant Exon 14 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.2159T>A p.Ile720Lys missense_variant Exon 14 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.2159T>A p.Ile720Lys missense_variant Exon 14 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.2159T>A p.Ile720Lys missense_variant Exon 14 of 15 1 ENSP00000413212.2 A0A0C4DG82

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152202
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000156
AC:
33
AN:
212026
AF XY:
0.000114
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000357
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000186
Gnomad OTH exome
AF:
0.000926
GnomAD4 exome
AF:
0.000263
AC:
378
AN:
1437076
Hom.:
0
Cov.:
31
AF XY:
0.000244
AC XY:
174
AN XY:
712282
show subpopulations
African (AFR)
AF:
0.0000904
AC:
3
AN:
33170
American (AMR)
AF:
0.000504
AC:
21
AN:
41650
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25542
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39106
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82802
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51928
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5726
European-Non Finnish (NFE)
AF:
0.000308
AC:
338
AN:
1097736
Other (OTH)
AF:
0.000219
AC:
13
AN:
59416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152320
Hom.:
0
Cov.:
33
AF XY:
0.000188
AC XY:
14
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41574
American (AMR)
AF:
0.000196
AC:
3
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000318
Hom.:
0
Bravo
AF:
0.000351
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000245
AC:
2
ExAC
AF:
0.0000998
AC:
12

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:9Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary erythromelalgia Pathogenic:1Uncertain:2Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Dec 01, 2021
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 02, 2014
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been previously reported as disease-causing and was found once in our laboratory in a 61-year-old female with Bell's palsy, Melkersson-Rosenthal syndrome, right-sided trigeminal neuralgia, fibromyalgia, hyperlipidemia, hyperglycemia, thunderclap headache, similarly affected mother and siblings (not tested). Additionally, this variant has been seen twice in younger individuals without related phenotypes (a 35-year-old female and a 14-year-old male). -

Jan 05, 2023
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:2Benign:1
Apr 16, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 29, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN9A c.2159T>A (p.Ile720Lys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 212026 control chromosomes. This frequency does not allow conclusions about variant significance. c.2159T>A has been reported in the literature in individuals presenting with features of Small nerve fiber neuropathy (SFN), inherited erythromelalgia (IEM), Charcot-Marie-Tooth disease Type 2 (CMT2), Paroxysomal extreme pain disorder (PEPD) (example, Faber_2012, Goldberg_2012, Antoniadi_2015, Cannon_2016). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in impaired slow inactivation resulting in neuronal hyperexcitability due to increased number of action potentials resulting from an increase in the number of channels available for activation close to the resting potential of dorsal root ganglion (DRG) neurons (Faber_2012). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (Likely benign, n=2; VUS, n=3). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

May 04, 2022
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Uncertain:2Benign:1
Mar 26, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

-
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Small fiber neuropathy Pathogenic:1Benign:1
Jan 01, 2012
OMIM
Significance:Pathogenic
Review Status:flagged submission
Collection Method:literature only

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:2
Jul 15, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in patients with small fiber neuropathy or Charcot-Marie-Tooth type 2, who did not have any other variants identified in the SCN9A gene (PMID: 25250524, 27525141, 26392352); Published functional studies demonstrate that I720K causes a gain of function by altering channel inactivation leading to hyperexcitability of the neurons (PMID: 21698661); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22803682, 27525141, 23280954, 22035805, 26392352, 30672368, 33144682, 25250524, 21698661, Newton2025[Preprint], 26633545) -

May 18, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Nov 29, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.I720K variant (also known as c.2159T>A), located in coding exon 13 of the SCN9A gene, results from a T to A substitution at nucleotide position 2159. The isoleucine at codon 720 is replaced by lysine, an amino acid with dissimilar properties. This alteration has been detected in the heterozygous state in multiple patients with adult-onset pain disorders (Cannon A et al. Case Rep Neurol Med, 2016 Jul;2016:9212369; Faber CG et al. Ann. Neurol., 2012 Jan;71:26-39; Goldberg YP et al. Pain, 2012 Jan;153:80-5). Expression of p.I720K in HEK293 cells showed impaired slow inactivation and caused DRG neurons to be hyperexcitable with a 43% reduction in current threshold (Faber CG et al. Ann. Neurol., 2012 Jan;71:26-39). However, given the population frequency of this alteration based on data from the Genome Aggregation Database (gnomAD), it is considered unlikely to cause dominant disease. Its pathogenicity for recessive disease remains unknown. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of primary erythermalgia/small fiber neuropathy and paroxysmal extreme pain disorder (PEPD), ; however, its contribution to the development of congenital insensitivity to pain (CIP) and hereditary sensory autonomic neuropathy type II (HSAN2D) is uncertain. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal extreme pain disorder Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.28
CADD
Uncertain
24
DANN
Benign
0.95
DEOGEN2
Uncertain
0.58
.;D;.;.;D;.;.
Eigen
Uncertain
0.21
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.83
T;.;T;D;T;T;D
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.21
T;T;T;T;T;T;T
MetaSVM
Uncertain
0.53
D
MutationAssessor
Benign
1.7
.;L;.;.;L;L;.
PhyloP100
7.4
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-4.5
D;.;.;.;.;D;.
REVEL
Pathogenic
0.69
Sift
Pathogenic
0.0
D;.;.;.;.;D;.
Sift4G
Benign
0.14
T;T;.;.;.;T;.
Vest4
0.59
MVP
0.86
MPC
0.27
ClinPred
0.15
T
GERP RS
5.9
Varity_R
0.79
gMVP
0.56
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200945460; hg19: chr2-167137018; API